Trade Summary

1 week ago, Imran Talat, serving as Chief Executive Officer at Rani Therapeutics Holdings, Inc. (RANI), purchased 35,000 shares at $0.72 per share, for a total transaction value of $25,193.00. Following this transaction, Imran Talat now holds 469,736 shares of RANI.

This purchase represents a 8.05% increase in Imran Talat's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, July 17, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 21, 2026 at 6:29 PM ET, 4 days after the trade was made.

Rani Therapeutics Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.